Ephraim J. Fuchs - Concepedia

Author

Ephraim J. Fuchs

Also Known As

E Fuchs, E J Fuchs, E. Fuchs, E. J. Fuchs, E.J Fuchs, E.J. Fuchs, Ephraim Fuchs, Ephraim J Fuchs, Ephraim J. Fuchs, Ephraim Joseph Fuchs

311

Publications

19K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Medicine Medical College of Wisconsin Fred Hutch Cancer Center

About

Ephraim J. Fuchs is an author at Johns Hopkins University specializing in medicine, immunology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	45	5K
2	Health Sciences	10	10	518
3	Allergy	4	4	623
4	Natural Sciences	1	1	84
5	Biochemistry	1	1	84

Ephraim J. Fuchs

124

Publications

15.8K

Citations

H-Index

Page 1

	Year	Citations
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide Leo Luznik, Paul V. O’Donnell, Heather J. Symons, Biology of Blood and Marrow Transplantation	2008	1.9K
Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells J P Ridge, Ephraim J. Fuchs, Polly Matzinger Science Immune ToleranceNewborn T CellsNeonatal Tolerance RevisitedAdaptive Immune SystemImmunology	1996	762
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia Stefan O. Ciurea, Mei-Jie Zhang, Andrea A. Bacigalupo, Blood	2015	645
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts Claudio G. Brunstein, Ephraim J. Fuchs, Shelly L. Carter, Blood	2011	588
B Cells Turn Off Virgin But Not Memory T Cells Ephraim J. Fuchs, Polly Matzinger Science Cell TherapyLymphocyte DevelopmentT-regulatory CellImmunologyT Cells	1992	569
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide Paul V. O’Donnell, Leo Luznik, Richard J. Jones, Biology of Blood and Marrow Transplantation ImmunologyImmunotherapyPosttransplantation CyclophosphamideHematological MalignancyBone Marrow Failure	2002	474
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease Javier Bolaños‐Meade, Ephraim J. Fuchs, Leo Luznik, Blood	2012	433
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease Leo Luznik, Javier Bolaños‐Meade, Marianna Zahurak, Blood	2010	396
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide Christopher G. Kanakry, Sudipto Ganguly, Marianna Zahurak, Science Translational Medicine	2013	354
Durable engraftment of major histocompatibility complex–incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide Leo Luznik, Sanju Jalla, Laura Engstrom, Blood	2001	335

Page 1